Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
04/1996
04/02/1996US5503989 Production of peptide amides
04/02/1996US5503978 Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
03/1996
03/28/1996WO1996009411A1 Antigen binding peptides (abtides) from peptide libraries
03/28/1996CA2200684A1 Antigen binding peptides (abtides) from peptide libraries
03/27/1996EP0702696A1 Trifunctional antithrombin and antiplatelet peptides
03/27/1996EP0702692A1 Regulation of antigen presentation
03/27/1996EP0702691A1 New thiodepsipeptide isolated from a marine actinomycete
03/27/1996EP0702570A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION
03/27/1996EP0702558A1 Novel opioid peptide inhibitors
03/27/1996CN1119457A Bone stimulating factor
03/27/1996CN1119441A AZA cyclohexapeptide compounds
03/26/1996US5502036 Viricides
03/26/1996US5502035 Hormone inhibitors
03/26/1996US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases
03/26/1996US5502032 Peptides, the preparation and use thereof
03/21/1996WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
03/21/1996WO1996008509A1 Anti-fungal peptides
03/21/1996WO1996008507A1 Aza cyclohexapeptide compounds
03/21/1996WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy
03/21/1996WO1996008275A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996WO1996008267A1 Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
03/21/1996WO1996008266A1 Aza cyclohexapeptide compounds
03/21/1996WO1996008264A1 Synthetic antibiotics
03/21/1996DE4433479A1 Proteins isolated from Boophilus microplus
03/21/1996CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996CA2199746A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
03/20/1996EP0701448A1 Amplification of the vitamin b 12? uptake system using polymers
03/20/1996EP0701447A1 Cyclohexapeptidyl propanolamine compounds
03/20/1996EP0449973B1 Polypeptide-polymer conjugates active in wound healing
03/20/1996CN1031344C Process for preparing peptides inhibiting maturation of T-lymphocytes and activity of macrophages
03/19/1996US5500414 Derivatives of peptides usable as inhibitors of bacterial collagenases
03/19/1996US5500413 Process for manufacture of 1-deamino-8-D-arginine vasopressin
03/19/1996CA1338171C Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
03/14/1996WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
03/14/1996WO1996007671A1 Racemization-free preparation of n-amino acid derivatives and dipeptides
03/14/1996WO1995035376A3 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains
03/13/1996EP0700998A1 Recombinant mersacidin and a method for production
03/13/1996EP0700430A1 Methods for selectively stimulating proliferation of t cells
03/13/1996EP0700302A1 Method of treating diabetes mellitus
03/13/1996EP0700301A1 Peptides and compounds that bind to elam-1
03/13/1996EP0491007B1 Structural alterations of the egf receptor gene in human gliomas
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996EP0428602B1 Polypeptides and dna encoding same
03/13/1996CN1118601A Inhibitors of herpes viral ribonucleotide reductase
03/13/1996CN1118573A Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
03/13/1996CN1118572A HLA-A2.1 combined peptide and application of same
03/13/1996CN1031242C 化妆品组合物 Cosmetic composition
03/12/1996US5498601 Rgd sequence
03/07/1996WO1996006857A1 Immunostimulatory agents
03/07/1996WO1996006630A1 Methods and compositions for modulating a t cell response
03/07/1996WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
03/07/1996DE4431513A1 Racemisierungsfreie Herstellung und Verwendung von N-Methoxy- oder -Hydroxy-benzyl-Aminosäurederivaten und -Dipeptiden Racemization preparation and use of N-methoxy-benzyl or hydroxy-protected dipeptides and amino acid derivatives
03/07/1996CA2198348A1 Analgesic method with dynorphin analogues truncated at the n-terminus
03/06/1996EP0699209A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS
03/06/1996EP0699208A1 Novel peptide nucleic acids
03/06/1996EP0476059B1 Methods for enhancing the rate of modification of metastable bonds
03/06/1996EP0449955B1 Synthetic hiv-like peptides, their compositions and uses
03/06/1996CN1031193C Polypeptide and method for preparing same
03/05/1996US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev
03/05/1996US5496724 Genes encoding platelet aggregation inhibitors
03/05/1996US5496551 Polypeptide immunogens
02/1996
02/29/1996WO1996006353A1 Lysine/leucine polypeptides, mixture sets and libraries thereof
02/29/1996WO1996006111A1 Regulatable elimination of gene expression, gene product function and engineered host cells
02/29/1996WO1996006109A1 An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
02/29/1996WO1996005858A1 Haemophilus adherence and penetration proteins
02/29/1996CA2197562A1 Haemophilus adherence and penetration proteins
02/29/1996CA2197242A1 Regulatable elimination of gene expression, gene product function and engineered host cells
02/28/1996EP0698614A1 Endothelin-antagonizing peptide
02/28/1996EP0698613A1 Endothelin-antagonizing peptide
02/28/1996EP0698103A1 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE
02/28/1996EP0698101A1 Hepatitis-c virus type 4, 5 and 6
02/28/1996EP0698091A1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
02/28/1996EP0698089A1 Nucleic acid encoding amp-activated protein kinase
02/28/1996EP0698040A1 Lhrh antagonists
02/28/1996EP0698039A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock
02/28/1996EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region
02/28/1996EP0697879A1 Cyclohexapeptidyl aminoalkyl ethers
02/28/1996EP0362367B1 Osteogenic devices
02/27/1996US5495000 Anticoagulant peptides
02/27/1996US5494999 For assaying, purifying or inducing cdw52 antibody
02/27/1996US5494893 Stylostatin 2
02/27/1996US5494809 Culturing and incubating cells of bacillus amyloliquefaciens
02/27/1996US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence
02/27/1996US5494679 Molecules for iontophoretic delivery
02/27/1996US5494672 Pseudomonas peptide composition and method
02/22/1996WO1996005221A1 Calcitonin receptor
02/22/1996WO1996005220A1 Compounds for use in treatment of carcinomas
02/22/1996WO1996005219A1 Purified form of streptogramines, preparation thereof and pharmaceutical compositions containing it
02/22/1996WO1996005218A1 Delivery of nucleic acids
02/22/1996WO1996004928A1 Calcitonin gene related peptide receptor
02/22/1996WO1996004927A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
02/22/1996WO1996004926A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ η1 CHAIN
02/22/1996DE4418691A1 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer 3 '- (4') non-radioactively labeled nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid-spacer
02/22/1996CA2196053A1 Two non-contiguous regions contribute to nidogen binding to a single egf-like motif of the laminin .gamma.1 chain
02/22/1996CA2173727A1 Novel gnrh analogues with antitumour effects and pharmaceutical compositions thereof
02/21/1996EP0696919A1 Diagnosis and treatment of erectile dysfunction